First Header Logo Second Header Logo

Difference in the rate of ocular adverse events with dupilumab between asthma and atopic dermatitis patients.

Wang Y, Jorizzo J. Difference in the rate of ocular adverse events with dupilumab between asthma and atopic dermatitis patients. Int J Dermatol. 2021 Mar 14.

View in: PubMed